Chembio Diagnostics, Inc. (CEMI): Price and Financial Metrics
CEMI Price/Volume Stats
Current price | $0.46 | 52-week high | $1.24 |
Prev. close | $0.45 | 52-week low | $0.19 |
Day low | $0.45 | Volume | 351,600 |
Day high | $0.46 | Avg. volume | 661,416 |
50-day MA | $0.43 | Dividend yield | N/A |
200-day MA | $0.45 | Market Cap | 16.71M |
CEMI Stock Price Chart Interactive Chart >
Chembio Diagnostics, Inc. (CEMI) Company Bio
Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. The company was founded in 1985 and is based in Medford, New York.
Latest CEMI News From Around the Web
Below are the latest news stories about CHEMBIO DIAGNOSTICS INC that investors may wish to consider to help them evaluate CEMI as an investment opportunity.
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced it has completed its acquisition of Chembio Diagnostics, Inc. (“Chembio”), a leading point-of-care diagnostics company focused on infectious diseases. Chembio is now part of Biosynex Group. The comp |
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023Failure to tender shares could result in the termination of the proposed merger between Chembio and BiosynexMEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 Fellow Chembio Stockholders, We strongly urge you to tender your shares of common stock of Chembio Diagno |
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.STRASBOURG, France, April 13, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a Nevada corporation and its wholly-owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued and outstanding shares of common stock (the “Shares”) of Chembio Diagnostics, Inc. (Nasd |
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 Fellow Chembio Stockholders, As previously communicated, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 31, 2023, |
Chembio’s CEO Letter to StockholdersReminder to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023MEDFORD, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 3, 2023 Fellow Chembio Stockholders, As previously communicated, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agree |
CEMI Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | 6.95% |
3-year | -86.59% |
5-year | -91.71% |
YTD | N/A |
2023 | 0.00% |
2022 | -80.73% |
2021 | -76.00% |
2020 | 4.17% |
2019 | -19.43% |
Continue Researching CEMI
Want to see what other sources are saying about Chembio Diagnostics Inc's financials and stock price? Try the links below:Chembio Diagnostics Inc (CEMI) Stock Price | Nasdaq
Chembio Diagnostics Inc (CEMI) Stock Quote, History and News - Yahoo Finance
Chembio Diagnostics Inc (CEMI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...